Technology advocate Techpoint is considering merging into the Central Indiana Corporate Partnership–a move that would leave CICP CEO Mark Miles atop all three of Indiana’s major business-development initiatives.
Four former top scientists at Eli Lilly and Co. have formed a Carmel-based company to develop diabetes therapies–a venture observers say has the potential to become the kind of blockbuster success BioCrossroads was built to stimulate.
Labs are nearing capacity at Strand Analytical Laboratories, which provides forensic and paternity DNA testing. In the second year of Scott Newman’s business, the former prosecutor predicts 2007 revenue will reach $4 million.
Clarian North Medical Center has stumbled out of the gate, with the Carmel hospital reporting losses in its first six months of operation that “well exceed” expectations, a new report says.
Eli Lilly and Co. has picked an insurer it knows extremely well to cover future problems in the high-stakes world of product liability litigation–itself. The Indianapolis drugmaker opted for self-insurance after struggling to find coverage in what it terms a “very restrictive insurance market.”
Jim Prieur makes a great choice for Conseco Inc. CEO, analysts say. But whether his hiring bodes well for the company’s Carmel headquarters is a different question. Conseco Chairman Glenn Hilliard said last week that Prieur will live in Chicago when he joins the company next month.
Indiana University leaders believe their researchers can spawn 100 new companies, pump $2.4 billion into the state's economy, help create 14,000 jobs, and generate a $2.25 return for every dollar spends if the General Assembly will invest in their bold life sciences strategy.
Dow AgroSciences LLC has brought on a team of people to push Natreon vegetable oil to purveyors of French fries and other deep-fried foods in the quest to eliminate much of the trans fat that now clogs arteries around the country.
The building skeleton planted recently at the corner of 65th Street and Binford Boulevard offers only a hint of the $29 million medical complex Ken Schmidt wants to grow there. The Indianapolis developer will add four more buildings and a separate pharmacy to the 17 acres of land he bought several years ago. The end result, he said, will be a medical plaza that offers a unique blend of services encompassing dental work, radiology and ambulatory surgery, among other specialties….
Advantis Medical Inc. manufactures custom trays and cases for orthopedic surgical devices. That core product line brought Advantis some $5.2 million in revenue in 2004, double the amount of the previous year, said Advantis President Jim Spencer.